| EPR | Enhanced permeability and retention |
| ROS | Reactive oxygen species |
| RT | Radiotherapy |
| WHO | World Health Organization |
| EBRT | External beam radiation therapy |
| LINACs | Linear particle accelerators |
| TRT | Targeted radionuclide therapy |
| SOCs | Standards of care |
| LET | Linear energy transfer |
| BNCT | Boron neutron capture therapy |
| OARs | Organs at risk |
| TME | Tumor microenvironment |
| SSBs | Single-strand breaks |
| DSBs | Double-strand breaks |
| PARP | Poly-ADP ribose polymerase |
| NP | Nanoparticle |
| AGuIX | Activation and Guidance of Irradiation by X-ray |
| GMP | Good manufacturing practice |
| MRI | Magnetic resonance imaging |
| WBRT | Whole brain radiation therapy |
| SE | Signal enhancement |
| EES | Extracellular extravascular space |
| % ID | Percentage of the injected dose |
| SD | Standard deviation |
| LIBS | Laser-induced breakdown spectroscopy |
| ICP-MS | Inductively coupled plasma mass spectrometry |
| ICP-OES | Inductively coupled plasma optical emission spectrometry |
| TEM | Transmission electron microscopy |
| FITC | Fluorescein isothiocyanate |
| Cy5.5 | Cyanine 5.5 |
| EEA1 | Early endosome antigen 1 |
| AIF | Apoptosis-inducing factor |
| LAMP-1 | Lysosome-associated membrane protein 1 |
| AF488 | Alexa Fluor 488 |
| IV | Intravenous |
| NIST | National Institute of Standards and Technology |
| DOTA | 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid |
| LQ | Linear quadratic |
| SF | Survival fraction |
| SER | Sensitizing enhancement ratio |
| MC | Monte Carlo |
| FFF | Flattening filter free |
| RBE | Relative biological effectiveness |
| LEM | Local effect model |
| DEFs | Dose enhancement factors |
| TDRA | Theory of dual radiation action |
| DER | Dose enhancement ratio |
| DCFDA | 2′,7′-dichlorofluorescein diacetate |
| DHR123 | Dihydrorhodamine 123 |
| H2DCFDA or DCFH-DA | 2′,7′-dichlorodihydrofluorescein diacetate |
| M-H2DCFDA | 5-(and-6)-chloromethyl-H2DCFDA |
| mROS | Mitochondrial ROS |
| cROS | Cytosolic ROS |
| GSH | Glutathione |
| SEM | Standard error of the mean |
| ATM | Ataxia–telangiectasia mutated |
| ATR | Ataxia–telangiectasia and Rad3-related protein |
| DDR | DNA damage response |
| HR | Homologous recombination |
| NHEJ | Non-homologous end-joining |
| IF | Immunofluorescence |
| AGE | Agarose gel electrophoresis |
| FM | Fluorescence microscopy |
| cGAS | Cyclic guanosine monophosphate–adenosine monophosphate synthase |
| IFN | Interferon |
| STING | Stimulatory interferon genes |
| IHC | Immunohistochemistry |
| Unk | Unknown |
| BRCA1 | Breast cancer 1 |
| FACS | Fluorescence-activated cell sorting |
| PI | Propidium iodide |
| ANOVA | Analysis of variance |
| APC | Allophycocyanin |
| 7-AAD | 7-Aminoactinomycin D |
| SPECT/CT | Single-photon emission computed tomography/computed tomography |
| TUNEL | Terminal deoxynucleotidyl transferase dUTP nick end labeling |
| H-SCORE | Histochemistry score |
| LC3B | Microtubule-associated protein 1 light chain 3B |
| BODIPY | Boron-dipyrromethene |
| MDA | Malondialdehyde |
| 4-HNE | 4-hydroxynonenal |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| GPX4 | Glutathione peroxidase 4 |
| ns | Non-significant |
| ICD | Immunogenic cell death |
| DAMPs | Damage-associated molecular patterns |
| HMGB1 | High-mobility group box 1 |
| CRT | Calreticulin |
| DCs | Dendritic cells |
| TAMs | Tumor-associated macrophages |
| ICIs | Immune checkpoint inhibitors |
| PD-1 | Programmed cell death protein 1 |
| NK | Natural killer |
| PBMC | Peripheral blood mononuclear cells |
| NOX2 | NADPH oxidase 2 |
| IRF5 | Interferon regulatory factor 5 |
| iNOS | Inducible nitric oxide synthase |
| TOM20 | Translocase of the outer mitochondrial membrane 20 |
| AMPK | Adenosine monophosphate activated protein kinase |
| AMPKT172* | Activated protein kinase on threonine 172 |
| Tregs | Regulatory T cells |
| MDSCs | Myeloid-derived suppressor cells |
| TDLNs | Tumor-draining lymph nodes |
| PMA | Phorbol-12-myristate 13-acetate |
| ROIs | Regions of interest |
| scRNA-seq | Single-cell RNA sequencing |
| IL | Interleukin |
| Tf | Transferrin |